Harvard Alumnus James E. Rothman Shares Nobel Prize In Medicine

Yale cell biologist, two others, are recognized for work on vesicles and cellular transport.

James E. Rothman, Ph. D. '76—now Wallace professor of biomedical sciences at Yale, chair of the medical school's department of cell biology, and founding director of Yale's nanobiology institute—has been awarded the 2013 Nobel Prize in Physiology or Medicine with Randy W. Schekman, of the University of California, Berkeley, and Thomas C. Südhof, of Stanford. The three scientists were recognized for "their discoveries of machinery regulating vesicle traffic, a major transport system in our cells."

According to Rothman's biography, he earned his Ph.D. degree in biological chemistry and was a student at Harvard Medical School from 1971 to 1973. From 1976 to 1978, he was a fellow in MIT's department of biology. From 1978 to 1988, he was a professor in the department of biochemistry at Stanford. He was Squibb professor of molecular biology at Princeton from 1988 to 1991 and then founded and chaired the department of cellular biochemistry and biophysics at Memorial Sloan-Kettering Cancer Center (1991-2004), where he served as vice-chairman of Sloan-Kettering. Before moving to Yale in 2008, Rothman was Wu professor of chemical biology and director of Columbia University’s Sulzberger Genome Center.

His biography cites discovery of 

key molecular machinery responsible for transfer of materials among compartments within cells, providing the conceptual framework for understanding such diverse and important processes as the release of insulin into the blood, communication between nerve cells in the brain, and the entry of viruses to infect cells. Numerous kinds of tiny membrane-enveloped vesicles ferry packets of enclosed cargo. Each type of vesicle must deliver its specialized cargo to the correct destination among the maze of distinct compartments that populate the cytoplasm of a complex animal cell. The delivery process, termed membrane fusion, is fundamental for physiology and medicine, as pathology in this process can cause metabolic, neuropsychiatric and other diseases. Rothman reconstituted vesicle budding and fusion in a cell-free system (1984) and discovered the complex of SNARE proteins (1993) which mediates membrane fusion and affords it specificity. He also uncovered the GTPase-switch mechanism which controls coated vesicle budding in the cell (1991).

You might also like

In Sermon, Garber Urges Harvard Community to ‘Defend and Protect’ Institutions

Harvard’s president uses traditional Memorial Church address to encourage divergent views.

How Do Single-Celled Organisms Learn and Remember

A Harvard neuroscientist’s quest to model memory in single-celled organisms

This Astronomer Is Sounding a Warning On 'Space Junk'

As debris accumulates in low Earth orbit, the danger of destructive collisions continues to rise.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.

Harvard Art Historian Jennifer Roberts Teaches the Value of Immersive Attention

Teaching students the value of deceleration and immersive attention

Explore More From Current Issue

David McCord in suit reading a book at cluttered wooden desk in office filled with framed art and shelves.

The Pump Celebrates Its 85th Birthday

Giving Harvard traditions their due 

Book cover of "Black Moses" by Caleb Gayle with subtitle about ambition and the fight for a Black state.

Civil Rights In the American West

A new book chronicles one man’s quest for a Black state.

Vivian W. Rong sitting on bench outdoors.

Highlighting Harvard Magazine’s Fellows

The 2025-2026 Ledecky and Summer Undergraduate Fellows